Related Experiment Video
Updated: Feb 21, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA‑24‑2 is associated with cell proliferation, invasion, migration and apoptosis in renal cell carcinoma
Lu Jin1, Yifan Li1, Liping Nie2
1Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
Abstract:
Micro (mi)RNAs are involved in multiple cellular processes, and alterations in miRNA expression have been demonstrated to lead to tumorigenesis. Previous microarray analysis revealed that miRNA (miR)‑24 was downregulated in renal cell carcinoma (RCC). Additionally, miR‑24 has been identified as an oncogene and tumor suppressor in various cancers. The present study assessed the expression levels of two stem‑loops of miR‑24, miR‑24‑1 and miR‑24‑2, in RCC tissues and paired healthy tissues by reverse transcription‑quantitative polymerase chain reaction. The results revealed that miR‑24‑2 was upregulated in RCC tissues and ACHN, 786‑O and 769P cell lines compared with healthy tissues and HEK‑293T cells, respectively, whereas miR‑24‑1 was almost absent in RCC and healthy kidney tissues. To investigate the role of miR‑24‑2 in RCC, a synthesized miR‑24‑2 mimic, negative control (NC), inhibitor or inhibitor NC was transfected into 786‑O and ACHN RCC cells, and cell proliferation, mobility and apoptosis assays were performed. The results of the present study revealed that miR‑24‑2 was associated with cell proliferation, migration, invasion and apoptosis, thus demonstrating that miR‑24‑2 may serve a role as an oncogene in RCC. Further studies are required to investigate the signaling pathways of miR‑24‑2, and the potential of miR‑24‑2 as a therapeutic target or biomarker for the early detection of RCC.
Insights
MicroRNAs (miRNAs) play a role in cancer. This study found miR-24-2 is upregulated in renal cell carcinoma (RCC) and promotes cancer cell proliferation, migration, and invasion, suggesting it may be an oncogene in RCC.
Area of Science:
- Molecular Biology
- Oncology
- Gene Expression Regulation
Background:
- MicroRNAs (miRNAs) are crucial regulators of cellular processes, and their dysregulation is linked to tumorigenesis.
- Previous studies indicated miR-24 downregulation in renal cell carcinoma (RCC), with conflicting roles as an oncogene or tumor suppressor in various cancers.
Purpose of the Study:
- To investigate the expression levels of miR-24-1 and miR-24-2 in RCC tissues and cell lines.
- To elucidate the functional role of miR-24-2 in RCC cell proliferation, migration, invasion, and apoptosis.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to assess miR-24-1 and miR-24-2 expression.
- miR-24-2 mimic and inhibitor transfections were performed in RCC cell lines (786-O and ACHN).
- Cell proliferation, migration, invasion, and apoptosis assays were conducted to evaluate miR-24-2's function.
Main Results:
- miR-24-2 was significantly upregulated in RCC tissues and cell lines (ACHN, 786-O, 769P) compared to healthy controls and HEK-293T cells.
- miR-24-1 expression was nearly absent in both RCC and healthy kidney tissues.
- Overexpression of miR-24-2 promoted RCC cell proliferation, migration, and invasion, while its inhibition suppressed these processes.
- miR-24-2 was found to influence apoptosis in RCC cells.
Conclusions:
- miR-24-2 acts as an oncogene in renal cell carcinoma, promoting key cancer hallmarks.
- miR-24-2 warrants further investigation for its signaling pathways and potential as a therapeutic target or early detection biomarker for RCC.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

